Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial
Authors:
Open Access
- 14 May 2024
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 22 (11) , 2211-2220.e10
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Review article: potassium‐competitive acid blockers for the treatment of acid‐related disordersAlimentary Pharmacology & Therapeutics, 2021
- The Value of Early Wireless Esophageal pH Monitoring in Diagnosing Functional Heartburn in Refractory Gastroesophageal Reflux DiseaseDigestive Diseases and Sciences, 2013
- Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non‐erosive reflux diseaseAlimentary Pharmacology & Therapeutics, 2009
- Functional heartburn vs. non‐erosive reflux disease: similarities and differencesAlimentary Pharmacology & Therapeutics, 2008
- Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux DiseaseDigestive Diseases and Sciences, 2005
- Effects of pantoprazole 20 mg in mildgastroesophageal reflux disease: Once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long termCurrent Therapeutic Research, 2005
- Esomeprazole 20 mg on‐demand is more acceptable to patients than continuous lansoprazole 15 mg in the long‐term maintenance of endoscopy‐negative gastro‐oesophageal reflux patients: the COMMAND StudyAlimentary Pharmacology & Therapeutics, 2004
- Effectiveness of proton pump inhibitors in nonerosive reflux diseaseClinical Gastroenterology and Hepatology, 2004
- Esomeprazole resolves chronic heartburn in patients without erosive oesophagitisAlimentary Pharmacology & Therapeutics, 2003
- Reflux symptom relief with omeprazole in patients without unequivocal oesophagitisAlimentary Pharmacology & Therapeutics, 1996